Blood pressure medication recalled nationwide under FDA’s Class II risk level
Inventia Healthcare Limited recalled about 13,567 bottles after the tablets failed dissolution tests, and the FDA said exposure could cause reversible harm.
- On Sept 17, 2026, the FDA issued a nationwide Class II recall for Inventia Healthcare Limited's 25 mg Chlorthalidone tablets. This classification indicates potential for temporary or medically reversible health consequences.
- Inventia Health initiated the recall after the medication failed to meet dissolution specifications, specifically impacting batch RISA24002 identified in the official alert.
- Approximately 13,567 bottles containing 100 pills each are affected by this recall, representing the total volume currently subject to the FDA safety alert.
- The same manufacturer previously recalled approximately 11,460 bottles in June, and FOX has reached out to Inventia Health for comment on the current recall.
- Information for this recall was sourced from an FDA alert issued on Sept 17, 2026, and previous reporting by LiveNOW from FOX, with the story reported from San Jose.
83 Articles
83 Articles
FDA recalls blood pressure medication: Reason, affected drugs, and should you stop taking the pills?
The FDA has urgently recalled more than 25,000 bottles of Chlorthalidone tablets from Inventia Healthcare. This recall is prompted by failures in critical dissolution testing, raising serious concerns about the medication’s efficacy for high blood pressure and fluid retention. It’s important for patients to review their medications and discuss any necessary adjustments with healthcare providers. The situation further emphasizes the ongoing safet…
UPDATE: FDA expands recall of blood pressure medication to include 13K+ bottles
The Food and Drug Administration (FDA) has issued a recall for thousands of bottles of a commonly prescribed blood pressure medication after testing revealed “failed dissolution specifications. ”
Pills that don't fully dissolve are now at the center of a nationwide blood-pressure drug recall. Inventia Healthcare Limited of Mumbai, India, is sweating 13.567 bottles of 25mg chlorthalidone tablets after finding them may not break down correctly in the body—meaning patients could get less medication than preshribed,...
Coverage Details
Bias Distribution
- 88% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium




















